These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17172671)

  • 21. Factors influencing the production of recombinant SV40 vectors.
    Vera M; Prieto J; Strayer DS; Fortes P
    Mol Ther; 2004 Oct; 10(4):780-91. PubMed ID: 15451462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quiescent subpopulations of human CD34-positive hematopoietic stem cells are preferred targets for stable recombinant adeno-associated virus type 2 transduction.
    Paz H; Wong CA; Li W; Santat L; Wong KK; Chatterjee S
    Hum Gene Ther; 2007 Jul; 18(7):614-26. PubMed ID: 17638572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-integrating lentiviral vectors based on the minimal S/MAR sequence retain transgene expression in dividing cells.
    Xu Z; Chen F; Zhang L; Lu J; Xu P; Liu G; Xie X; Mu W; Wang Y; Liu D
    Sci China Life Sci; 2016 Oct; 59(10):1024-1033. PubMed ID: 27614752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Titering replication-defective rSV40 vectors.
    Strayer DS; Mitchell C; Maier DA; Nichols CN
    Cold Spring Harb Protoc; 2010 Jun; 2010(6):pdb.prot5437. PubMed ID: 20516175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.
    Philippe S; Sarkis C; Barkats M; Mammeri H; Ladroue C; Petit C; Mallet J; Serguera C
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17684-9. PubMed ID: 17095605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Integration of AAV vectors and insertional mutagenesis].
    Rossi A; Salvetti A
    Med Sci (Paris); 2016 Feb; 32(2):167-74. PubMed ID: 26936174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibiting AIDS in the central nervous system: gene delivery to protect neurons from HIV.
    Cordelier P; Van Bockstaele E; Calarota SA; Strayer DS
    Mol Ther; 2003 Jun; 7(6):801-10. PubMed ID: 12788654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral gene therapy.
    Mancheño-Corvo P; Martín-Duque P
    Clin Transl Oncol; 2006 Dec; 8(12):858-67. PubMed ID: 17169759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential of recombinant SV40-based vectors for gene therapy.
    Buscail L; Cordelier P
    Recent Pat DNA Gene Seq; 2007; 1(2):93-9. PubMed ID: 19075921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type and position of promoter elements in retroviral vectors have substantial effects on the expression level of an enhanced green fluorescent protein reporter gene.
    Flasshove M; Bardenheuer W; Schneider A; Hirsch G; Bach P; Bury C; Moritz T; Seeber S; Opalka B
    J Cancer Res Clin Oncol; 2000 Jul; 126(7):391-9. PubMed ID: 10929761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature.
    Young JL; Benoit JN; Dean DA
    Gene Ther; 2003 Aug; 10(17):1465-70. PubMed ID: 12900761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
    Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS
    J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocyte-specific gene expression from integrated lentiviral vectors.
    Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
    J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Episomal transgene expression in pluripotent stem cells.
    Lufino MM; Popplestone AR; Cowley SA; Edser PA; James WS; Wade-Martins R
    Methods Mol Biol; 2011; 767():369-87. PubMed ID: 21822889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How Simian Virus 40 Hijacks the Intracellular Protein Trafficking Pathway to Its Own Benefit … and Ours.
    Toscano MG; de Haan P
    Front Immunol; 2018; 9():1160. PubMed ID: 29892296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SV40 pseudovirions as highly efficient vectors for gene transfer and their potential application in cancer therapy.
    Kimchi-Sarfaty C; Gottesman MM
    Curr Pharm Biotechnol; 2004 Oct; 5(5):451-8. PubMed ID: 15544493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene delivery to the liver using simian virus 40-derived vectors.
    Strayer DS; Zern MA
    Semin Liver Dis; 1999; 19(1):71-81. PubMed ID: 10349685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter.
    Harms JS; Splitter GA
    Hum Gene Ther; 1995 Oct; 6(10):1291-7. PubMed ID: 8590733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo functional characterization of gutless recombinant SV40-derived CFTR vectors.
    Mueller C; Strayer MS; Sirninger J; Braag S; Branco F; Louboutin JP; Flotte TR; Strayer DS
    Gene Ther; 2010 Feb; 17(2):227-37. PubMed ID: 19890354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.
    Pandya S; Boris-Lawrie K; Leung NJ; Akkina R; Planelles V
    Hum Gene Ther; 2001 May; 12(7):847-57. PubMed ID: 11339901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.